These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 338271)

  • 1. Pediatric psychopharmacology. A review with special reference to deanol.
    Oettinger L
    Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):25-31. PubMed ID: 338271
    [No Abstract]   [Full Text] [Related]  

  • 2. Deanol in minimal brain dysfunction.
    Lewis JA; Lewis BS
    Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):21-4. PubMed ID: 590062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Academy of Pediatrics Committee on Children with Disabilities, Committee on Drugs: Medication for children with an attention deficit disorder.
    Pediatrics; 1987 Nov; 80(5):758-60. PubMed ID: 3670981
    [No Abstract]   [Full Text] [Related]  

  • 4. Disruptive behavior, hyperactivity, and learning disabilities in children with Tourette's syndrome.
    Walkup JT; Scahill LD; Riddle MA
    Adv Neurol; 1995; 65():259-72. PubMed ID: 7872144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deanol and methylphenidate in minimal brain dysfunction.
    Lewis JA; Young R
    Clin Pharmacol Ther; 1975 May; 17(5):534-40. PubMed ID: 1092513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention-deficit/hyperactivity disorder: a life-span perspective.
    Biederman J
    J Clin Psychiatry; 1998; 59 Suppl 7():4-16. PubMed ID: 9680048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal brain dysfunctions in children.
    Peters JE
    Am Fam Physician; 1974 Jul; 10(1):115-23. PubMed ID: 4834966
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug therapy in the treatment of minimal brain dysfunction.
    Saccar CL
    Am J Hosp Pharm; 1978 May; 35(5):544-52. PubMed ID: 26219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Children with attention deficit disorders with hyperactivity; the role of drugs in treatment].
    van der Gaag RJ; Buitelaar JK
    Ned Tijdschr Geneeskd; 1991 Jul; 135(28):1261-6. PubMed ID: 1861762
    [No Abstract]   [Full Text] [Related]  

  • 10. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment.
    Torres AR; Whitney J; Gonzalez-Heydrich J
    Epilepsy Behav; 2008 Feb; 12(2):217-33. PubMed ID: 18065271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention deficit hyperactivity disorder across the lifespan: the child, adolescent, and adult.
    Greydanus DE; Pratt HD; Patel DR
    Dis Mon; 2007 Feb; 53(2):70-131. PubMed ID: 17386306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tricyclic antidepressants in the treatment of children with attention deficit disorder.
    Pliszka SR
    J Am Acad Child Adolesc Psychiatry; 1987 Mar; 26(2):127-32. PubMed ID: 3584008
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Need for medication in minimal brain dysfunction.
    Levitis KA
    Pediatrics; 1974 Sep; 54(3):388. PubMed ID: 4414312
    [No Abstract]   [Full Text] [Related]  

  • 15. Application of actigraphy in the clinical setting: use in children with attention-deficit hyperactivity disorder.
    Miller LG; Kraft IA
    Pharmacotherapy; 1994; 14(2):219-23. PubMed ID: 8197043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamines in the management of children's hyperkinesis.
    Singh V; Ling GM
    Bull Narc; 1979; 31(3-4):87-94. PubMed ID: 44685
    [No Abstract]   [Full Text] [Related]  

  • 17. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MBD: advanced in understanding many bothersome dilemmas.
    Seals JR
    Adv Pediatr; 1976; 23():113-49. PubMed ID: 795279
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged P300 latency in attention deficit hyperactivity disorder predicts poor response to imipramine.
    Sangal JM; Sangal RB; Persky B
    Clin Electroencephalogr; 1996 Oct; 27(4):191-201. PubMed ID: 9465283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate (ritalin) and other drugs for treatment of hyperactive children.
    Med Lett Drugs Ther; 1977 Jul; 19(13):53-5. PubMed ID: 865414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.